🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of the Ultrasound-guided Percutaneous Neuromodulation on the Mean Velocity in Crossfit Practitioners.

RecruitingNAAges 18 Years - 60 YearsAllCEU San Pablo University
NCT07684534 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This randomized controlled blinded clinical trial aims to evaluate the effect of ultrasound-guided percutaneous neuromodulation (US-guided PNM) targeting the innervation of the transversus abdominis muscle on squat performance in CrossFit practitioners. The transversus abdominis is a deep trunk muscle that contributes to lumbopelvic stability and force transmission during functional and athletic movements. Previous research suggests that improving neuromuscular activation of the trunk musculature may enhance movement efficiency and performance during resistance exercises. Ultrasound-guided percutaneous neuromodulation is a minimally invasive technique that applies electrical stimulation through a needle placed close to a peripheral nerve under ultrasound guidance, with the aim of modulating neuromuscular function. Healthy male and female CrossFit practitioners aged 18 to 60 years, with

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age between 18 and 60 years * At least 1 year of CrossFit training experience * Training frequency between 2 and 6 sessions per week Exclusion Criteria: * Belonephobia (fear of needles) * Presence of cardiac conditions or implanted cardiac devices (e.g., pacemaker) * Pregnancy * Active oncological process * Skin conditions or lesions in the intervention area * Neurological or neurosensory disorders * Epilepsy * Current febrile condition * Recent use of antibiotics * Treatment with anticoagulant medication * Use of medications that may affect physical performance * Autoimmune diseases or use of immunosuppressive therapy * Active lumbar or abdominal pathology * Recent lumbar surgery or operations related to the intervention area * Active musculoskeletal injury or pain affecting squat technique or -performance * Undiagnosed pain affecting execution of the sporting movement.
💊

What it tests

  • ultrasound-guided percutaneous neuromodulation
  • ultrasound-guided percutaneous neuromodulation (sham)
📍

Where

1 site
Fisiosport premium SL
Murcia, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy